From June 5 through June 8, 2026, the American Diabetes Association (ADA) is hosting its annual Scientific Sessions in New Orleans, Louisiana. As the largest and most prominent diabetes conference in the world, the annual meeting sees over 12,000 researchers and clinicians gather together to discuss the latest advancements in diabetes and obesity research, clinical care, and technical innovation. 

Today’s preview highlights currently scheduled sessions that attendees will not want to miss. Dates and times are current as of Thursday, April 30, 2026. For a complete look at the ADA 2026 Scientific Sessions schedule, view the full program.

Friday, June 5
  • Hope or Hype? Microbiome as New Frontier for Type 2 Diabetes and Obesity
    • 12:45 PM – 1:45 PM
  • Beyond Conventional Care: Regenerative Medicine and Smart Dressings for Diabetic Foot Ulcer
    • 12:45 PM – 1:45 PM
  • Redesigning Diabetes Care: What Is the Cost?
    • 12:45 PM – 1:45 PM
  • Adapting Diabetes Care for All
    • 2:00 PM – 3:30 PM
  • From Plate to Pancreas: Mechanisms Linking Diet to Diabetes
    • 2:00 PM – 3:30 PM
  • Multiomic Approaches and Resources for Providing Insights into Diabetes Pathophysiology
    • 2:00 PM – 3:30 PM
  • Mapping Diabetes: Epidemiology in a Changing U.S. Demographic Landscape
    • 3:45 PM – 5:15 PM
  • Amylin as a Novel Diabetes and Obesity Therapy
    • 3:45 PM – 5:15 PM
  • Personalizing Diabetes Care: Tailoring the Intervention to the Cardiovascular Risk
    • 3:45 PM – 5:15 PM
  • Frontiers in Diabetic Nerve Health: Biomarkers, Risk, Diagnosis, and Treatment
    • 5:30 PM – 6:30 PM
  • Top Clinical Abstracts: Kidney Complications in Diabetes
    • 5:30 PM – 6:30 PM
  • Dual Agonism in Type 1 Diabetes: Unveiling Efficacy and Safety of Adjunct Therapy with CT-868 (GLP-1/GIP RA) in Adults with Type 1 Diabetes—Phase 1 and 2 Results
    • 5:30 PM – 6:30 PM
Saturday, June 6
  • AI Integration into Diabetes Technology
    • 8:00 AM – 9:30 AM
  • The ADA's Standards of Care in Diabetes: 2026 Updates
    • 8:00 AM – 9:30 AM
  • Educating Patients with Diabetes beyond the Clinic Walls
    • 11:30 AM – 12:30 PM
  • Discussion on Diabetes in Primary Care: Optimizing Use, Safety, and Tolerability of Diabetes Medications
    • 11:30 AM – 12:30 PM
  • Reimaging Clinical Type 1 Diabetes Care
    • 12:30 PM – 1:30 PM
  • Contemporary and Emerging Diabetes Technologies and Therapies: Psychosocial and Behavioral Considerations
    • 1:30 PM – 3:00 PM
  • Next-Generation Diabetic Foot Ulcer Care: AI, Cell Reprogramming, and 3D Bioprinting
    • 1:30 PM – 3:00 PM
  • GLP-1 Receptor Agonists: The Optimal First-Line Therapy for Early Pediatric Type 2 Diabetes?
    • 3:15 PM – 4:15 PM
  • Newer Concepts in Management of Diabetes and Hypertriglyceridemia
    • 3:15 PM – 4:15 PM
  • Beta-Cell Replacement in Pediatric Type 1 Diabetes: Promise and Perspective
    • 4:30 PM – 6:00 PM
  • Joint ADA/AACC Symposium: Expecting the Best—Laboratory Issues in the Diagnosis and Management of Diabetes in Pregnancy
    • 4:30 PM – 6:00 PM
  • DETECT - ADA 2026 - From Detection to Intervention: Applying Disease-Modifying Therapies and Preserving Beta Cell Function in Type 1 Diabetes
    • 6:15 PM – 9:15 PM
  • On Track With Chronic Kidney Disease: The Race to Early Detection and Risk Reduction in Type 1 and Type 2 Diabetes
    • 6:15 PM – 9:15 PM
Sunday, June 7
  • Metabolic and Glycemic Profiles in Pregnancies Affected by Diabetes
    • 8:00 AM – 9:30 AM
  • From Evidence to the Plate: What the New Nutrition Guidelines Mean for Diabetes Care
    • 8:00 AM – 9:30 AM
  • Emerging Insights from Type 1 Diabetes Immunotherapy Clinical Trials
    • 8:00 AM – 9:30 AM
  • The Social Context of Life with Diabetes
    • 11:30 AM – 12:30 PM
  • Discussion on Public Health and Epidemiology: Leveraging Technology to Disseminate Diabetes Care to Under-Resourced Populations
    • 11:30 AM – 12:30 PM
  • Diabetes Risk and Prediction: One Size Does Not Fit All
    • 12:30 PM – 1:30 PM
  • Addressing the Growing Diabetes Epidemic: Global Perspectives
    • 1:30 PM – 3:00 PM
  • ADA Diabetes Care Symposium: The Oscillation of Diabetes and the Environment
    • 1:30 PM – 3:00 PM
  • Determinants of ß-Cell Immunogenicity and Survival in Type 1 Diabetes
    • 3:15 PM – 4:15 PM
  • Update of the ADA-EASD Consensus Report on the Management of Type 1 Diabetes in Adults
    • 3:15 PM – 4:15 PM
  • Early Pregnancy Diabetes Screening Reexamined: GO MOMs or Hold Tight?
    • 4:30 PM – 6:00 PM
  • Metabolic Control in Obesity and Diabetes via Interoception
    • 4:30 PM – 6:00 PM
  • Sarcopenia and Diabetes Care: Muscle Health and Targeted Nutrition
    • 6:15 PM – 9:15 PM
Monday, June 8
  • Diabetes Technology Use across Life Situations
    • 8:00 AM – 9:30 AM
  • Lady Parts (of Life with Diabetes): Behavioral and Psychosocial Care for Women
    • 8:00 AM – 9:30 AM
  • Maternal Metabolic Imprinting: New Insights on Developmental Origins of Diabetes and Obesity
    • 8:00 AM – 9:30 AM
  • Diabetes in Pregnancy: Mechanisms, Management, and Metabolic Imprinting
    • 11:30 AM – 12:30 PM
  • Discussion on Diabetes Technology: Addressing Unmet Needs in Diabetes Technology—Expanding Access to Devices
    • 11:30 AM – 12:30 PM
  • Discussion on Foot Care: Revolutionizing Diabetic Limb Salvage—Vascular Innovation, Bone Health, and Regenerative Strategies in Lower Extremities
    • 11:30 AM – 12:30 PM
  • Transformational Translational Research in Diabetes
    • 12:30 PM – 1:30 PM
  • Preventing Diabetes-Related Complications
    • 1:30 PM – 3:00 PM
  • Managing Diabetes across the Cancer Continuum: From Treatment to Survivorship
    • 1:30 PM – 3:00 PM
  • B Cells in Type 1 Diabetes: Hidden Culprits or Passive Participants?
    • 3:15 PM – 4:15 PM
  • How Does MASLD Impact Lipoprotein Biology and Cardiovascular Risk with Obesity and Diabetes?
    • 3:15 PM – 4:15 PM

Sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.